| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.02B | 25.28B | 27.26B | 25.43B | 15.52B | 11.39B |
| Gross Profit | 12.54B | 12.62B | 15.95B | 15.66B | 12.51B | 10.43B |
| EBITDA | 6.75B | 6.61B | 7.67B | 7.23B | 5.90B | 4.86B |
| Net Income | 4.03B | 4.14B | 4.28B | 4.19B | 3.50B | 2.77B |
Balance Sheet | ||||||
| Total Assets | 477.11B | 478.15B | 436.54B | 395.72B | 376.75B | 335.09B |
| Cash, Cash Equivalents and Short-Term Investments | 53.69B | 74.54B | 62.70B | 48.66B | 65.81B | 59.73B |
| Total Debt | 43.90B | 44.68B | 43.45B | 16.70B | 13.57B | 15.84B |
| Total Liabilities | 441.40B | 442.81B | 403.45B | 366.49B | 13.57B | 15.84B |
| Stockholders Equity | 34.15B | 33.81B | 31.57B | 28.47B | 24.88B | 21.48B |
Cash Flow | ||||||
| Free Cash Flow | 4.04B | 11.09B | 3.40B | 819.00M | -2.01B | 3.48B |
| Operating Cash Flow | 4.78B | 11.79B | 4.23B | 2.01B | -946.00M | 4.46B |
| Investing Cash Flow | -38.83B | -37.49B | -26.71B | -29.30B | -28.26B | -25.50B |
| Financing Cash Flow | 24.66B | 28.94B | 35.81B | 12.68B | 33.69B | 38.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ₪53.58B | 9.60 | 16.87% | 4.11% | 12.78% | 1.42% | |
70 Outperform | ₪100.66B | 9.94 | 15.67% | 3.70% | 17.99% | 9.86% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | ₪36.62B | 9.13 | 13.10% | 3.69% | 22.83% | -5.05% | |
64 Neutral | ₪92.53B | 9.95 | 15.13% | 3.54% | 20.24% | 17.76% | |
58 Neutral | ₪23.36B | 10.57 | 15.81% | 4.57% | 21.26% | -5.22% |